Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.

Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the leading global provider of precision medical solutions. The company's core team has more than 20 years of senior industry experience, involved in cancer genomics, genetics and bioinformatics and other fields. Based on its core technical advantages, the Company aims at precision medicine, establishes a cooperative relationship with middle and downstream enterprises in the industry, and forms a complete industrial chain from academic research to clinical product transformation. It has also established close cooperation with many large-scale third-party inspection agencies including Illumina, Well-known domestic and foreign hospitals and research institutes to establish cooperative relations, the development of a series of independent intellectual property rights and international competitiveness of clinical testing products for patients, doctors and medical institutions to provide accurate, convenient and comprehensive services.

Oncotherapy science (OTS) is“ to deliver cancer therapeutics and treatments with higher efficacy and fewer side effects to patients suffering from cancer as soon as possible, and to overcome the fight against cancer. Was established with the aim of OTS brought Professor Genomix (Science that handles genetic information systematically) as a pioneer in the medical field with Prof. Atsushi Nakamura (Director, Cancer Precision Medical Research Center, Institute of Cancer, Professor Emeritus, The University of Tokyo, Professor Emeritus of Chicago University) Joint research to identify target molecules suitable for cancer drug development based on comprehensive gene expression analysis, and promote research and development of small molecule drugs, cancer peptide vaccines and antibody drugs for those targets.

Epigenomics is a molecular diagnostics company focusing on the development and commercialization of in vitro diagnostic tests for cancer. Its cancer diagnostic tests aim at finding cancer at early stages before symptoms occur and are carried out conveniently on body fluids such as blood plasma. These tests potentially address millions of individuals in each of the major markets such as the United States, Europe, and Japan and provide product opportunities each with peak sales potentials of several hundred millions of euros for diagnostics companies worldwide. Its lead test development program is in colorectal cancer. Further test are in development for lung and prostate cancer. Each of its products in development addresses either mass markets or high-value niches. While some of them lend themselves to partnering with established diagnostics industry players, others can be commercialized effectively by Epigenomics itself. The concept of its diagnostic tests in development relies on detecting differences in DNA methylation patterns between healthy and sick individuals or between subgroups of patients for disease classification.

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

Sansure Biotech, Inc. engages in the research, development, production, and sales of diagnostic reagents and instruments. It also provides third-party medical testing services. The company's products include viral hepatitis, genital infection & genetics, pediatric infection, respiratory infection, nucleic acid blood screening, scientific research, public health, animal disease, nucleic acid extraction, and biochemical series reagents; automatic nucleic acid detection reaction system, and point-of-care testing mobile molecular diagnostic system series instrument; and fluorescence polymerase chain reaction assay software. Sansure Biotech was founded on April 23, 2008 and is headquartered in Changsha, China.

Beijing Institute of Genomics, Chinese Academy of Sciences (doing business as China Academy of Sciences Beijing Jiyinzu Research Laboratory) is a Chinese private company located in Beijing. The firm provides medical research services.

Exact Sciences Development Co. LLC, part of EXACT Sciences Corp., is an American company. The firm engages in research and development diagnostic test for cancer.

Shenrui Bio is a biological tech enterprise integrating research and development, production, and sales of medical devices and in vitro diagnostic reagents. They also provide screen printing electrode biosensor engineering technology services.

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Shanghai Huizhong Tongkang Biotechnology Co., Ltd., established on 2021-07-20, Business scope includes general items:engaged in biotechnology(genetically modified organism,Except human stem cell genetic diagnosis)technical services in the field,technology development,technical consulting,technology transfer;Sales of bio-based materials;Research and development of bio-based materials technology(genetically modified organism,Except human stem cell genetic diagnosis);Research and development of bio-based material polymerization technology(genetically modified organism,Except human stem cell genetic diagnosis);Biochemical product technology research and development(genetically modified organism,Except human stem cell genetic diagnosis);Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Machinery sales;Instrument sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Domestic trade agent;Engineering and Technology Research and Experimental Development(genetically modified organism,Except human stem cell genetic diagnosis).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Class III medical device business;Inspection and testing service;Technology Import and Export;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

Beijing Origin Juhe Biotechnology Co., Ltd., established on 2020-07-27, Business scope includes technical promotion services;Import and export;Technology Import and Export;Agent import and export;software development;Business Management Consulting;Conference Services;Production of class Ι medical devices;Sales Ι,Class II medical device,computer,Software and Auxiliary Equipment;Educational Consulting;Medical Research(Does not include medical activities);health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Sales of Class III Medical Devices;Production of the second class,Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of the second class,Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.).

Guangzhou Kingmed Center For Clinical Laboratory Co., Ltd. provides clinical and laboratory testing services. It offers clinical trials, medical examination, food and hygiene testing, physical examination, scientific research services, and quality management. The company was founded by YaoMing Liang in 1994 and is headquartered in Guangzhou, China.

KeyGene NV provides its partners and customers in the plant breeding industry contract research, partnerships and molecular genetic services. It delivers novel enabling technologies and applications to support companies and institutes that carry out fundamental or applied genetic genomic research and that seek to enhance the quality of their products through the improvement of their genetic material. The company was established in 1989 and is headquartered in Wageningen, the Netherlands.

Centre Hospitalier Universitaire Vaudois (doing business as Lausanne University Hospital) is a private company headquartered in Lausanne, Switzerland, that operates university hospitals.\nThe company says this about itself: The CHUV, Lausanne University Hospital, is one of the five university hospitals in Switzerland. With its 16 clinical and medico-technical departments and their numerous services, the CHUV is renowned for its academic achievements in health care, research, and teaching. The CHUV is also a well-known center of medical education and research thanks to its collaboration with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). The CHUV has been recognized as one of the World?s 10 best hospitals according to the 2021 ranking of Newsweek magazine. It is with enthusiasm, that the Chairman of the Department of Urology, Prof Beat Roth, will pursue and support the research and studies with this novel treatment for bladder cancer.

Guangzhou Dajian Biotechnology Co., Ltd., established on 2009-06-16, Business scope includes medical research and experimental development;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Operation of non-licensed medical devices(i.e. no application required<Medical device operating enterprise license>ready-to-operate medical device",Including Class I medical devices and national regulations do not require application<Medical device operating enterprise license>Ready-to-operate Class II Medical Devices);Medical supplies and equipment retail(Does not contain drugs and medical devices);Import and export(Excluding franchised products);Technology Import and Export;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business(apply<Medical device operating enterprise license>medical device",Including the third class of medical devices and need to apply<Medical device operating enterprise license>Class II medical devices that can only be operated);medical diagnosis,Monitoring and treatment equipment retail;medical diagnosis,Monitoring and treatment equipment manufacturing;Sanitary materials and medical supplies manufacturing;

Anhui Dajian Medical Technology Co., Ltd., established on 2015-08-21, Business scope includes biotechnology development services;Medical Research and Experimental Development;Medical equipment rental service;software development;Biotechnology Consulting,communication service;Clean and purification engineering design and construction;Furniture manufacturing and installation;air conditioner,Ventilation system installation services;Fire engineering construction;Manufacturing of medical laboratory equipment and appliances;Manufacturing of Laboratory Analytical Instruments;Interior decoration engineering design and construction;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);medical diagnosis,Manufacture of monitoring and treatment equipment,wholesale,retail;Biopharmaceuticals;Class I Class II Class III Medical Devices(Contains in vitro diagnostic reagents)production,wholesale,Sales;Manufacturing of chemical preparations(Removal of hazardous chemicals,highly toxic chemicals,precursor chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**